期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
错配修复蛋白缺失相关子宫内膜癌的病理特征及其临床意义 被引量:3
1
作者 邓茜 雷琼 +10 位作者 李璐 高尤亮 俞文英 严俊龙 郭亚男 郑时玉 李海莉 蒙伶俐 卢立霞 李征 夏朝霞 《浙江医学》 CAS 2021年第16期1739-1743,I0006,共6页
目的探讨错配修复蛋白缺失相关子宫内膜癌(dMMR-EC)的病理特征及其临床意义。方法选取2014年6月至2017年6月宁波市临床病理诊断中心诊断的子宫内膜癌(EC)患者294例,收集其临床病理资料,复阅病理切片并分析肿瘤组织学类型、肌层浸润、淋... 目的探讨错配修复蛋白缺失相关子宫内膜癌(dMMR-EC)的病理特征及其临床意义。方法选取2014年6月至2017年6月宁波市临床病理诊断中心诊断的子宫内膜癌(EC)患者294例,收集其临床病理资料,复阅病理切片并分析肿瘤组织学类型、肌层浸润、淋巴结转移及国际妇产科协会(FIGO)分级分期等临床病理特征。采用免疫组化法检测肿瘤组织中人体碱基错配修复(MMR)蛋白(包括MLH1、PMS2、MSH2和MSH6)的表达,采用二代测序方法检测部分病例肿瘤组织MMR基因突变频谱,分析MMR蛋白阴性率与临床病理特征的相关性。结果294例EC患者中有62例(21.1%,62/294)为dMMR-EC,其中40例(13.6%,40/294)MLH1和(或)PMS2阴性,22例(7.5%,22/294)MSH2和(或)MSH6阴性。MMR蛋白阴性率与患者年龄、组织学类型、肌层浸润深度、淋巴结转移情况和FIGO分级分期均无明显相关性(均P>0.05)。非II型高级别ECMMR蛋白阴性率为35.5%,明显高于II型高级别EC的11.6%,差异有统计学意义(P<0.05)。随机选取21例dMMR-EC患者进行二代测序检测MMR基因突变频谱,16例出现MMR基因突变。62例dMMR-EC患者均进行随访,随访时间25~62个月,有效随访52例,其中无病生存49例,远处转移2例,病死1例,失访10例。结论推荐所有初次确诊EC的患者进行免疫组化初筛Lynch综合征相关子宫内膜癌,其中非II型高级别EC是重点筛查对象;采用免疫组化筛查高级别dMMR-EC,有助于高级别EC的预后预测并指导疾病的治疗和管理。 展开更多
关键词 子宫内膜癌 LYNCH综合征 免疫组化 错配修复基因/蛋白 病理
下载PDF
Mismatch repair gene hMSH2 protein as predictive maker for gastric carcinoma
2
作者 Feifei Liu Mei Li +3 位作者 Shuang Wen Zhaohui Wang Guowang Xu Shen Lv 《The Chinese-German Journal of Clinical Oncology》 CAS 2007年第1期37-39,共3页
Objective: To study the possibility of mismatch repair gene hMSH2 as a marker to predict the occurrence of gastric carcinoma. Methods: Immunohistochemical method was used to detect hMSH2 protein expressions of gastric... Objective: To study the possibility of mismatch repair gene hMSH2 as a marker to predict the occurrence of gastric carcinoma. Methods: Immunohistochemical method was used to detect hMSH2 protein expressions of gastric carci- nomas (carcinoma group) and their surrounding epithelia (surrounding epithelium group) in patients and the epithelia (normal epithelium group) in persons without carcinoma. Results: The positive rates of hMSH2 protein expression in nucleus of carcinoma, surrounding epithelium and normal epithelium groups were 44.94% (71/158), 28.48% (45/158) and 11.76% (4/34), respectively (P=0.000); the positive rates of hMSH2 protein expression in plasma of the 3 groups were 37.97% (60/158), 27.85% (44/158) and 23.53% (8/34), respectively (P=0.084); the positive rates of hMSH2 protein expression in both nucleus and plasma of the 3 groups were 20.89% (33/158), 17.72% (28/158) and 2.94% (1/34), respectively (P=0.045). Although the difference of positive rates between carcinoma and surrounding epithelium groups was not significant (P=0.476), both of them were higher than that of normal epithelium group (P=0.018). Conclusion: Our findings show that the detection of hMSH2 protein expression in gastric epithelia may help to predict and diagnose gastric carcinoma. 展开更多
关键词 mismatch repair gene HMSH2 gastric carcinoma immunohistochemical method
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部